# Evaluation of the Effectiveness and Safety of Remote Electrocardiographic Monitoring in Patients with Atrial Fibrillation Following Ablation Therapy

> **NCT06751459** · NA · NOT_YET_RECRUITING · sponsor: **HUINNO Co., Ltd** · enrollment: 270 (estimated)

## Conditions studied

- Atrial Fibrillation (AF)

## Interventions

- **DEVICE:** MEMO Patch 2 - 14-day Monitoring
- **DEVICE:** MEMO Patch 2 - 1-day Monitoring
- **DEVICE:** MEMO Link

## Key facts

- **NCT ID:** NCT06751459
- **Lead sponsor:** HUINNO Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-01-06
- **Primary completion:** 2026-08-01
- **Final completion:** 2027-03-01
- **Target enrollment:** 270 (ESTIMATED)
- **Last updated:** 2024-12-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06751459

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06751459, "Evaluation of the Effectiveness and Safety of Remote Electrocardiographic Monitoring in Patients with Atrial Fibrillation Following Ablation Therapy". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06751459. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*